共 50 条
- [41] An Approach to the Management of Rare Tumors THE LAM ET AL CASE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (09): : 841 - 841
- [43] Management of patients with cancer of unknown primary site - The Hainsworth/Greco article reviewed ONCOLOGY-NEW YORK, 2000, 14 (04): : 576 - +
- [44] The moving target of cancer care costs - The McKoy/Fitzner/Edwards et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (07): : 862 - +
- [45] Erlotinib in pancreatic cancer: A major breakthrough? The Senderowicz/Johnson/Sridhara et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (14): : 1706 - +
- [46] Discussing disease progression and end-of-life decisions - The Baile et al article reviewed ONCOLOGY-NEW YORK, 1999, 13 (07): : 1031 - 1032
- [47] Preventing Prostate Cancer Overdiagnosis From Becoming Overtreatment THE CROSWELL ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (06): : 468 - 478
- [48] Hepatocellular carcinoma: Neoadjuvant therapy reconsidered - The Almhanna/Kalmadi/Pelley et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1122 - +
- [49] Key developments in rectal cancer treatment - The Willet/Duda/Czito et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1075 - +
- [50] Follicular lymphoma: Expanding therapeutic options - The Ganti/Bociek/Bierman et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (02): : 234 - 235